‘The disease “cancer” is increasingly classified into sub-groups. Today, we are already dealing with a number of orphan diseases,’ says Professor Richard Greil MD, head of LIMCR at University Hospital Salzburg.
With 350,000 mammography screenings annually, Unilabs Sweden finds itself on the leading edge for research in mammography and pioneering patient education programmes. John Brosky reports
Study described in The New England Journal of Medicine is the first to show cause-and-effect relationship between a gene variant and calcium deposits on the aortic valve.
Researchers at Imperial College London have discovered a new way in which a very common childhood disease could be treated.
In 2013, the Robert‐Koch‐Stiftung will for the first time award a prize for excellent scientific research and practical measures in the field of hospital hygiene und infection prevention. Healthcare institutions such as hospitals and rehabilitation facilities and research institutes as well as individuals are invited to apply for the prize which is endowed with 50,000 €.
Sixty years ago, a research paper was published which was the first to describe the double-helix DNA structure.
Renowned French and German cardiovascular researchers gathered in October at the French Embassy in Berlin for a one-day symposium entitled ‘The Frontiers of Cardiovascular Research: From Basic Concepts to Novel Approaches in Therapy and Prevention’
A dynamic new consortium was launched in October during the recent Innovation in Oncology event organised by the German Cancer Research Centre (DKFZ) with Heidelberg University Hospital.
Despite receiving blood thinners and other clot prevention treatment, some patients still develop potentially lethal blood clots in the first month after their operations anyway, especially if they developed a surgical-site infection while in the hospital, according to results of a study at Johns Hopkins.
The formation of the National Institute for Health Research has made the field vastly stronger and the country is now placed second only to the USA, reports Mark Nicholls
Since its creation three years ago, the French National Alliance for Health and Life Sciences (Aviesan) has proved its full worth in scientific coordination, Annick Chapoy reports from Paris
Austrian specialist: If the science is not used the impact on crime detection will be negative.
The brain of mammals produces new neurons for the whole of their lives. This process, called neurogenesis, enables cognitive functions such as memory or learning, and its decrease is linked to some neuro-psychiatric pathologies and intellectual disabilities.
At RSNA 2012, Siemens is launching its new MRI addressing academic research centres and university hospitals. According to Bernd Ohnesorge, the Magnetom Prisma 3.0 T enforces the company’s major commitment to advancing research, bearing testimony to Siemens’ innovation leadership in the field. In Chicago, the CEO of the Siemens MRI business unit presented the 3 T system for which the company…
A novel, entirely biodegradable device has been successfully implanted in a blocked artery patient needing a percutaneous coronary intervention
Key trends in computer-assisted surgery and robotics dominated the agenda of the annual congress of the German Association for Computer- and Robotics-Assisted Surgery (CURAC), reports Michael Reiter.
New technologies for sensing chemicals that people are exposed to and their effects in the body will help scientists work towards a complete picture of how environmental pollutants influence health in a major EU initiative being launched yesterday.
European doctors and scientists are working on the StrokeBack project, a medical system aimed at supporting stroke patients in their rehabilitation. Modern technology helps affected patients to practise their mobility at home.
Germany hopes for better research conditions as revision of the EU Clinical Trials Directive is nigh
Personalised cancer medicine is much discussed, with high expectations for biomolecular decoding of various tumours and the global pharma industry developing targeted drugs to attack tumours at a biomolecular level.
Intelligent mounting systems featuring CIM med GmbH’s integrated data and power lines for anaesthetic technology increase hygiene in operating theatres and protect cables from damage, the manufacturer reports.
Nine British hospitals are working with National Health Service (NHS) Blood and Transplant (NHSBT) on an electronic reporting pilot that may offer quicker access to patient test results and data.
